MRCHF(MRCHF)
MRCHF
OTC • Last print unknown ago
$22.00—Stale · unknown old
No analyst ratings available
No analyst price targets available for MRCHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $266.66B | $278.21B | $289.54B |
| Low | $264.42B | $273.81B | $286.01B |
| High | $268.71B | $281.01B | $292.12B |
| EBITDA Avg | $28.98B | $32.98B | $35.86B |
| Low | $28.86B | $32.79B | $35.63B |
| High | $29.06B | $33.12B | $36.04B |
| EBIT Avg | $7.86B | $12.33B | $15.43B |
| Low | $7.74B | $12.14B | $15.19B |
| High | $7.94B | $12.46B | $15.60B |
| Net Income Avg | $5.91B | $9.52B | $12.03B |
| Low | $5.81B | $9.37B | $11.84B |
| High | $5.97B | $9.63B | $12.17B |
| EPS Avg | $105.10 | $169.41 | $214.05 |
| Low | $103.43 | $166.72 | $210.65 |
| High | $106.31 | $171.37 | $216.52 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $66.71B | $66.58B | $65.69B |
| Low | $66.71B | $66.58B | $65.69B |
| High | $66.71B | $66.58B | $65.69B |
| EBITDA Avg | $6.86B | $6.84B | $5.72B |
| Low | $6.86B | $6.84B | $5.72B |
| High | $6.86B | $6.84B | $5.72B |
| EBIT Avg | $1.86B | $1.86B | $772M |
| Low | $1.86B | $1.86B | $772M |
| High | $1.86B | $1.86B | $772M |
| Net Income Avg | $1.37B | $1.37B | $490M |
| Low | $1.37B | $1.37B | $490M |
| High | $1.37B | $1.37B | $490M |
| EPS Avg | $24.77 | $24.77 | $8.85 |
| Low | $24.77 | $24.77 | $8.85 |
| High | $24.77 | $24.77 | $8.85 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |